Cargando…

Factor Xa inhibitor for venous thromboembolism management in patient with cancer: a systematic review and meta-analysis

Background: An earlier systematic review reported no differences in the incidence of recurrent venous thromboembolism and major bleeding between factor Xa inhibitors and standard anticoagulation. The present meta-analysis aimed to assess the effectiveness of factor Xa inhibitors for the management o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nugroho Eko Putranto, Johanes, Wardhana, Ardyan, Noor, Yoga Alfian, Lambok Marnala Yosua Siahaan, Pirhot, Al Farabi, Makhyan Jibril
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802150/ https://www.ncbi.nlm.nih.gov/pubmed/35136585 http://dx.doi.org/10.12688/f1000research.73883.1

Ejemplares similares

Mechanical Occlusion Chemically Assisted Ablation (MOCA) for Saphenous Vein Insufficiency: A Meta-Analysis of a Randomized Trial
por: Nugroho, Johanes, et al.
Publicado: (2020)

Modification on acute myocardial infarction model through left anterior descending coronary artery ligation: An experimental study on rats (Rattus norvegicus) using readily available materials
por: Nugroho, Johanes, et al.
Publicado: (2019)

The role of factor Xa inhibitors in venous thromboembolism treatment
por: Cabral, Katherine P, et al.
Publicado: (2015)

Profile of cardiovascular disease risk in type 2 diabetes mellitus patients receiving statin therapy: A cross-sectional study
por: Ikhsan, Yasmin Karimah, et al.
Publicado: (2022)

Recognizing dialysis access steal syndrome with central vein stenosis as arteriovenous fistula complication: A case report
por: Suwanto, Denny, et al.
Publicado: (2022)

Diagnostic test accuracy of Xpert MTB/RIF for tuberculous pericarditis: a systematic review and meta-analysis
por: Andrianto, Andrianto, et al.
Publicado: (2020)

Direct oral Xa inhibitors for the treatment of venous thromboembolism after bariatric surgery
por: Kushnir, Margarita, et al.
Publicado: (2022)

Association between arteriovenous access flow and ventricular function: A cross-sectional study
por: Prastowo, Rachmat Ageng, et al.
Publicado: (2022)

Efficacy of Oral Factor Xa Inhibitor for Venous Thromboembolism in a Patient with Antithrombin Deficiency
por: Minami, Kentaro, et al.
Publicado: (2018)

The effect of oral anticoagulant use before visit for patients with COVID-19 on mortality: A meta-analysis
por: Ghea, Cornelia, et al.
Publicado: (2022)

No-reflow phenomenon during percutaneous coronary intervention in a patient with polycythemia vera: A case report
por: Oktaviono, Yudi Her, et al.
Publicado: (2020)

742 Evaluation of Anti-Xa Levels and Venous Thromboembolism Prophylaxis with Enoxaparin in Burn Patients
por: Boyd, Allison, et al.
Publicado: (2023)

The Impact of Classical Cardiovascular Risk Factors on Hospitalization and Mortality among Hajj Pilgrims
por: Ardiana, Meity, et al.
Publicado: (2023)

Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Advanced Chronic Kidney Disease
por: Ahuja, Tania, et al.
Publicado: (2021)

Correlation of inflammatory cytokines on corrected QT interval in rifampicin-resistant tuberculosis patients
por: Kusmiati, Tutik, et al.
Publicado: (2021)

The role of C-Reactive protein as an inflammatory marker to predict prolonged QTc interval in rifampicin-resistant tuberculosis patients: A case-control study
por: Kusmiati, Tutik, et al.
Publicado: (2021)

Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens
por: Kusmiati, Tutik, et al.
Publicado: (2022)

Predictive Value of Hematologic Indices in the Diagnosis of Acute Coronary Syndrome
por: Luke, Kevin, et al.
Publicado: (2019)

Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis
por: Andrianto, et al.
Publicado: (2021)

Assessment of anti-factor Xa activity of enoxaparin for venous thromboembolism prophylaxis in morbidly obese surgical patients
por: Al Otaib, Nouf, et al.
Publicado: (2017)

Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care
por: Zachariah, Seeba, et al.
Publicado: (2020)

Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition
por: Mavromanoli, Anna C., et al.
Publicado: (2021)

Scalp block for analgesia after craniotomy: A meta-analysis
por: Wardhana, Ardyan, et al.
Publicado: (2019)

Venous thromboembolism in COVID-19: A meta-summary of cases
por: ALGhasab, Naif Saad, et al.
Publicado: (2022)

Timing of symptomatic venous thromboembolism after surgery: meta-analysis
por: Singh, Tino, et al.
Publicado: (2023)

Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis
por: Santoso, Anwar, et al.
Publicado: (2021)

Human umbilical cord blood-mesenchymal stem cell-derived secretome in combination with atorvastatin enhances endothelial progenitor cells proliferation and migration
por: Oktaviono, Yudi Her, et al.
Publicado: (2021)

The effect of subchronic cigarette smoke exposure on oxidative stress parameters and endothelial nitric oxide synthase in a rat aorta
por: Ardiana, Meity, et al.
Publicado: (2021)

Evaluation of anti-Xa levels in patients with venous thromboembolism within the first 48 h of anticoagulation with unfractionated heparin
por: Nguyen, Lily, et al.
Publicado: (2023)

Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients
por: T Rocha, Ana, et al.
Publicado: (2007)

Cost-effectiveness of diagnostic strategies for venous thromboembolism: a systematic review
por: Zhang, Yuan, et al.
Publicado: (2022)

State-of-Art in the Age Determination of Venous Thromboembolism: A Systematic Review
por: Di Fazio, Nicola, et al.
Publicado: (2021)

A Systematic Review of the Guidelines on Venous Thromboembolism Prophylaxis in Gynecologic Oncology
por: Romano, Federico, et al.
Publicado: (2022)

Statistical Fragility of Venous Thromboembolism Prophylaxis Following Total Joint Arthroplasty
por: Sequeira, Sean B., et al.
Publicado: (2023)

Venous thromboembolism prophylaxis in patients with traumatic brain injury: a systematic review
por: Chelladurai, Yohalakshmi, et al.
Publicado: (2013)

Obesity as a Risk Factor for Venous Thromboembolism Recurrence: A Systematic Review
por: Ntinopoulou, Pinelopi, et al.
Publicado: (2022)

Venous Thromboembolism (VTE) in Post-Prostatectomy Patients: Systematic Review and Meta-Analysis
por: Wani, Mudassir, et al.
Publicado: (2023)

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome—A Single Center Prospective Study
por: Matyjek, Anna, et al.
Publicado: (2021)

TCTAP A-071 Comparison of Perindopril vs. Losartan With Regard to Pro-Coagulation Factors in Adipocytes Exposed to Sars-Cov-2 Spike Protein
por: Hermawan, Hanestya Oky, et al.
Publicado: (2023)

Optimised reversal without train-of-four monitoring versus reversal using quantitative train-of-four monitoring: An equivalence study
por: Wardhana, Ardyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tg5eakpao88jiin2fvqvuok65t